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Objective: This study investigates changes in the neuromuscular activation pattern of 
the lower limb muscles in stroke survivors when crossing obstacles of three different 
heights.
Methods: Eight stroke survivors and eight age-, height-, and gender-matched healthy 
controls were recruited and instructed to cross over obstacles with heights of 10, 20, 
and 30% leg length. Surface electromyography (EMG) signals were recorded from the 
rectus femoris (RF), biceps femoris (BF), tibialis anterior (TA), and medial gastrocnemius 
(MG) of both limbs. Muscle activation signals were normalized to maximum voluntary 
contraction. Differences between groups and heights were compared using the root 
mean square of EMG, the cocontraction index of agonist and antagonist muscles, and 
power spectral analysis based on the mean power frequency (MPF). The correlations 
between the calculated variables and clinical scales such as Berg Balance Scale and 
Fugl-Meyer assessment (FMA) were also examined.
results: During the leading limb swing phase, the activation levels of all four muscles 
were greater in the stroke group than the healthy controls (p < 0.05), and the TA showed 
increased activation level with increasing obstacle height in both groups (p <  0.05). 
Cocontraction between the TA and MG was higher in the stroke group during the 
swing phase of the leading limb and between the RF and BF during the stance phase 
(p < 0.05). Similarly, for the trailing limb, increased cocontractions between the two pairs 
of agonist and antagonist muscles were found during the stance phase in the stroke 
group (p < 0.05). During the crossing stride, the frequency analysis showed significantly 
smaller MPF values in all four lower limb muscles in the leading limb of stroke survivors 
compared with healthy controls (p < 0.05). Moreover, significant correlations were found 
between the FMA scores and the BF and TA activations in the leading limb during the 
swing phase (p < 0.05).
conclusion: Greater activation levels of the lower limb muscles resulted in higher mus-
cular demands for stroke survivors, which might lead to greater difficulty in maintaining 
balance. The increased cocontraction during obstacle crossing might be compensation 
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inTrODUcTiOn
Stroke is a leading cause of disability associated with a loss of 
ability to generate force, which results in activity limitations and 
has a negative impact on motor function (1). Following a stroke, 
motor control impairments such as weakness, slow movements, 
spasticity, fatigue, and incoordination often occur in the lower 
limbs, which lead to gait abnormalities (2).
Daily walking commonly involves avoiding obstacles, such as 
doorsteps, stones, and stairs, and stepping across obstacles has 
been demonstrated to require greater muscle force, increased 
balance control, and enhanced muscle coordination than level 
walking (3, 4). One study showed that almost half of the tested 
stroke survivors failed to step across an obstacle, and their ability 
to maintain balance was compromised (5). The loss of balance 
in stroke survivors during obstacle crossing may lead to a high 
risk of falls and cause soft tissue injuries or fractures. Therefore, 
it is important to analyze the characteristics of the motion during 
obstacle crossing in stroke survivors. In spite of compromised 
balance, it is possible that stroke survivors may use compensa-
tory strategies to avoid falls. It would therefore be helpful to 
understand the mechanism of preventing falls and ensuring safe 
crossing.
The balance and postural stability of stroke survivors have 
been quantified using kinematic and kinetic parameters, such 
as joint angles, joint moment, end-point distance, the distance 
between the center of mass and the center of pressure, and the 
ground reaction force (6–8). The balance was compromised in 
stroke survivors, and they might take a strategy involving greater 
pelvic posterior tilt and greater joint angles to ensure enough toe-
obstacle clearance compared with healthy controls during obstacle 
crossing. However, little has been investigated about the neuro-
muscular changes during obstacle crossing. Electromyography 
(EMG) signals recorded from the surface of the muscles show 
the activity of motor neurons, which can reflect the relative level 
of muscle activation and provide valuable information about 
muscle function (9). Hahn et al. compared the EMG signals of 
the lower limb muscles between the elderly and the young (10). 
They found that elderly adults were able to negotiate different 
heights during walking and that the higher muscular demands 
could lead to a high risk of falls. The level of activity was reduced 
in the hemiparetic muscles in stroke survivors compared with the 
normal subjects, while the muscle’s activity of the non-paretic side 
was increased compared with the normal subjects, which helped 
maintain standing balance in response to sideways pushes (11). 
However, the neuromuscular mechanism of maintaining balance 
when crossing obstacles of different heights remains to be inves-
tigated in stroke survivors. Stepping over obstacles of different 
heights requires varying the activation levels of the agonist and 
antagonist muscles. Muscle cocontraction is the simultaneous 
activity of agonist and antagonist muscles (12, 13). Kitatani et al. 
demonstrated increased muscle coactivation in the trailing limb 
of stroke survivors with increasing obstacle heights, which could 
increase postural stability and decrease the rate of trips (14). 
However, they did not compare the coactivation patterns between 
healthy subjects and stroke survivors during obstacle crossing to 
understand more about the coordination mechanism following 
stroke.
Electromyography signals can also be analyzed in the 
frequency domain based on the power spectrum to reflect the 
neuromuscular function. The mean power frequency (MPF) and 
median frequency (MF) mainly reflect changes in the conduc-
tion velocity of the active motor units which could be damaged 
after stroke (15). It has been speculated that alternations of the 
EMG spectrum are related to loss of muscle fibers, changes in 
the composition of motor unit type (peripheral), synchroniza-
tion of multiple motor units, and disorder control of motor unit 
(central factors). Many studies have investigated the relationship 
between muscle activation level and MPF and MF values for 
both healthy people and stroke survivors. Decreased MPF values 
are usually found in the muscles of the paretic side compared 
with the non-paretic side (16, 17). The amplitude of the EMG 
signals increases with the level of muscle force, but studies on the 
relationship between the EMG spectrum and contraction force 
remain uncertain. Hu et al. found slightly decreased MF values 
in the paretic biceps brachii with increased muscle contraction 
in stroke survivors (18), while Kaplanis et al. reported increased 
MF in the EMG of the biceps brachii with increased isometric 
torque in healthy subjects (19). EMG spectral analysis could help 
better understand the cause of neuromuscular changes in the 
stroke survivors during obstacle crossing, which has not been 
investigated in previous studies.
This study investigates neuromuscular changes in stroke sur-
vivors to maintain balance when crossing obstacles of different 
heights in comparison with healthy controls. We examined the 
relative muscle activation levels, the cocontraction of the agonist 
and antagonist muscles of the knee joint and ankle joint, and the 
power spectrum of the muscles, also their relationship with the 
clinical scales. The results may provide knowledge of the mecha-
nism of motor control during obstacle crossing and information 




Eight stroke survivors and eight healthy subjects matched by age, 
height, and gender were recruited in this study (Table 1). The inclu-
sion criteria for the stroke survivors included (i) the occurrence 
for the affected stability and enable safe crossing for stroke survivors. The reduced MPF 
in the affected limb of the stroke group might be due to impairments in motor units or 
other complex neuromuscular alterations.
Keywords: stroke, obstacle crossing, electromyography, gait analysis, activation pattern
TaBle 1 | Basic characteristics of study subjects.
characteristic stroke group (n = 8) control group 
(n = 8)
p-Value
Age, years (mean ± SD) 58.88 ± 10.61 60.62 ± 8.33 0.445
Height, cm 167.33 ± 7.35 165.51 ± 5.92 0.296
Mass, kg 63.57 ± 7.68 61.67 ± 8.94 0.392
Gender Male = 6, female = 2 Male = 6, 
female = 2




Berg test scores (range) 40.38 ± 6.94 (27–47) 56 ± 0 (56) <0.001a
FMA scores (range) 23.12 ± 3.48 (18–28) 34 ± 0 (34) <0.001a
aSignificant effect using an independent t-test.
FMA, Fugl-Meyer assessment scale of the motor function in paretic low-extremity (total 
score: 34).
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of a first stroke with unilateral hemiparesis lesions confirmed by 
magnetic resonance imaging or computed tomography; (ii) an 
interval of at least 3 months post-stroke; (iii) the ability to step 
across an obstacle height of 30% leg length; and (iv) the ability 
to sign an informed consent form. This study was approved by 
the Ethics Committee of the First Affiliated Hospital of Sun Yat-
sen University. All procedures were conducted according to the 
Declaration of Helsinki and all subjects provided written consent 
before the experiments. The motor function of stroke survivors 
was evaluated by an experienced physiotherapist based on the 
Berg Balance Scale (BBS) and Fugl-Meyer assessment (FMA) for 
lower extremities.
apparatus
Circular silver–silver chloride (Ag–AgCl) electrodes with a 
diameter of 5 mm and inter-electrode distance of 20 mm were 
bilaterally attached to the bellies of the rectus femoris (RF), 
biceps femoris (BF), tibialis anterior (TA), and medial gastroc-
nemius (MG) of the lower limbs of the subjects. The muscle 
groups showed obvious changes when stepping over obstacles 
(20). Eight pre-amplified wireless transmission modules (DTS 
Noraxon, Scottsdale, AZ, USA) at a gain of 4,000 were linked 
with the electrodes to record EMG signals at a sample frequency 
of 1 kHz.
A total of 35 spherical 15-mm infrared-reflective mark-
ers were fastened to the subject’s whole body according to the 
Vicon Plug-In Gait marker placement. A 6-camera 3D motion 
analysis system (Vicon Motion Systems, Oxford, UK) recorded 
the marker positions at a sample frequency of 100 Hz. Two force 
plates (464 mm × 508 mm × 83 mm, AMTI, Watertown, MA, 
USA) at a sample frequency of 1 kHz were placed in the middle of 
the path with the obstacle between them. All the EMG, kinematic, 
and kinetic signals were recorded simultaneously and processed 
by the Vicon Nexus operating system.
Procedure
Anthropometric characteristics were measured before the gait 
analysis (height, leg length, and bodyweight). Leg length was 
measured with scaled tape from the anterior superior iliac spine 
to the lateral malleolus and used to calculate the obstacle height 
of each individual. The electrodes and spherical markers were 
then attached to the corresponding locations on the subject. 
Before the electrode placement, the area around the muscles were 
shaved and cleaned with alcohol, and surgical tape was used as 
appropriate around the electrode and amplifier to obtain better 
EMG signals.
When the preparation was finished and the subjects had enough 
rest, the subjects were instructed to walk at a self-selected speed 
with bare feet  along an 8-m walkway with a height-adjustable 
obstacle placed midway. The leading limb was defined as the first 
limb to cross the obstacle. The stroke subjects were instructed to 
use their affected leg as the leading limb of the obstacle crossing, 
and the healthy controls were instructed to use their dominant 
leg. The obstacle was set to three height conditions (10, 20, and 
30% leg length). The three height conditions were performed 
in random order, and three trials of each height condition were 
recorded. Trials in which the subjects touched the obstacle were 
ignored and excluded from analysis. Prior to the trials, subjects 
visually and manually inspected the obstacle, and then practiced 
two to three trials according to the therapist’s instructions. 
Subjects were reminded to perform the task within their limits 
of safety and stop if they felt at risk. A therapist accompanied 
the subject and walked to the side to provide protection and 
assistance if required.
After all the trials were finished, the subject was asked to rest 
for a few minutes and then instructed to lay supine with the 
tested limb placed at 90° hip and knee flexion, and the other limb 
resting in neutral to perform maximum voluntary contraction 
(MVC) tests (21). Another experienced therapist held a hand-
held dynamometer (MicroFET3, Hoggan Inc., UT, USA; with 
the precision of 0.4 N and range from 13 to 1,330 N) stably as 
a resistance at the corresponding position of the measured joint 
(22), and the subject used tested muscle group to push maximally 
against the hand-held dynamometer for about 5  s. To measure 
the MVC of the TA and MG, the hand-held dynamometer was 
placed proximally to metatarsophalangeal joints on dorsal and 
plantar surface of foot. To measure the MVC of the RF and BF, 
the hand-held dynamometer was placed proximally to ankle on 
anterior and posterior surface of leg (23). The subject performed 
2–3 submaximum voluntary contractions before the MVC test 
began to become familiar with the test procedure. MVC test 
included knee flexion and extension, dorsiflexion, and plantar 
flexion, and the MVC was recorded three times for each muscle. 
During the MVC procedure, subjects were verbally encouraged 
to ensure maximal recruitment.
Data Processing
For all MVC and gait trials, raw EMG signals were collected at 
1  kHz, band-pass filtered through a fourth-order Butterworth 
filter with a bandwidth of 10–350  Hz, full-wave rectified, and 
low-pass filtered through a second-order Butterworth filter with 
a cut off frequency of 6 Hz. The root mean square was calculated 
during a particular phase of the gait. The filtered signals from 
the gait trials were then normalized to the MVC for each muscle 
to determine the relative activation levels. The calculation of the 
cocontraction index (CI) required two more steps with a linear 
envelope: (1) subtraction of the average resting EMG activity and 
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(2) normalization to the maximum value of EMG activation in 






( )∫  
where Aij(t) is the overlapping activity of EMG linear envelopes 
after subtraction and normalization for the agonist and antagonist 
muscles i and j, T is the length of the signal period. The CI value 
varies from 0 to 1. Zero means there is no overlapping of the two 
EMG envelopes, and 1 means the two muscles are fully activated 
to 100% MVC during the trial.
The MPF was calculated using the band-pass filtered signals 
(through a fourth-order Butterworth filter with a bandwidth of 
10–350 Hz) for each time window (the stance, swing, or entire 













where P(f) indicates the power intensity curve and f indicates the 
frequency. The kinematic data were filtered by a 20-Hz low-pass 
Butterworth filter. We considered the toe-off time to be when the 
toe marker was 2  mm off the ground and the heel-strike time 
as when the force platform received enough signals to make the 
measurement reliable (25). The gait cycle was then divided into a 
swing phase and stance phase for a single lower limb.
statistical analysis
Descriptive statistics (mean values and SD) were calculated for 
all dependent variables. The normalized EMG activation, CI, 
and MPF values were subjected to a repeated-measures two-way 
(group: stroke and control × obstacle height: 10, 20, and 30% of 
leg length) analysis of variance (ANOVA). The ANOVA results 
were adjusted using a Bonferroni post hoc test. If there was an 
interaction between the two effects, then one-way ANOVA 
was separately performed for the group effect and height effect. 
Pearson product–moment correlations were used to examine the 
relationships between the calculated variables and clinical scales. 
The level of significance was set at an alpha level of 0.05. All 
statistical analyses were done using SPSS 19 statistical software.
resUlTs
All subjects were able to complete the tasks with three different 
obstacle heights and the MVC tasks. No incidents of falling 
were observed, and we discarded the trials in which the subjects 
touched the obstacle or received help from the therapist. Subjects 
did not indicate discomfort during the tasks, nor did they show 
any feelings of fatigue.
The rectified and normalized EMG signals showed that the 
muscles were activated at a corresponding phase during the gait 
in a typical trial of a stroke subject and control subject (Figure 1). 
The muscle activation level and activation duration were greater 
among the stroke survivors than the healthy controls in the four 
muscles of the leading limb respectively. Also, there were some 
abnormal cocontractions among stroke survivors. For example, 
the TA and MG (a pair of agonist and antagonist muscles) had 
greater coactivation level in the stroke survivor (CI =  12.15%) 
compared to the healthy control (CI = 4.31%) during the swing 
phase of the obstacle crossing, as indicated by a circle in Figure 1.
The stroke survivors showed greater relative activation levels 
in the leading and trailing limbs compared to healthy controls 
(Table 2). For all height conditions during the swing phase, the 
TA activation of the stroke survivors reached an average of 41% 
of their maximum capacity, in contrast to 29% in the healthy con-
trols. Interactions were found between the groups and heights in 
the TA muscle of the leading limb during both swing and stance 
phases. The activation of the TA of the leading limb significantly 
increased with the obstacle height during both swing and stance 
phases (one-way ANOVA with post hoc tests, p < 0.05). The TA 
activation was significantly greater in the stroke survivors com-
pared to the healthy controls at the 20 and 30% heights during the 
swing phase and at 30% height during the stance phase (one-way 
ANOVA, p <  0.05). For the trailing limb, the activation of the 
BF and TA also significantly increased with the obstacle height 
during the swing phase (p < 0.05).
During the stance phase in the leading limb, the average CI for 
all height conditions of the RF and BF of the stroke survivors was 
17.95 ± 7.90%, which was significantly greater than the average 
of 13.81 ± 4.89% (p < 0.05) for the healthy controls. Also, the 
average CI of the TA and MG was also significantly higher for 
the stroke survivors (10.53 ±  5.54%) than the healthy controls 
(7.60 ± 2.98%) during the swing phase (p < 0.05). Similarly, in 
the trailing limb, the average CI of the RF and BF (15.51 ± 5.18%) 
and the TA and MG (14.33 ±  8.52%) were significantly larger 
among stroke survivors than the healthy controls (RF and BF: 
7.48 ±  2.39%, TA and MG: 7.85 ±  2.54%, p <  0.05), but only 
during the stance phase. The average CI showed no significant 
difference between stroke survivors and healthy controls in other 
conditions (p > 0.05).
Figure 2 shows the details of the CI at each obstacle height for 
both the leading and trailing limbs during the swing and stance 
phases. For the CI of the two muscle pairs of the leading limb, a 
between-group difference was found at the 30% height in the RF 
and BF and the 20 and 30% heights for the TA and MG (p < 0.05). 
There was a significant difference between the 10 and 30% and the 
20 and 30% heights for the RF and BF during the stance phase, as 
well as between the 10 and 30% and the 20 and 30% heights for 
the TA and MG (p < 0.05). For the trailing limb, between-group 
differences in CI were found during the stance phase except for 
the TA and MG at the 10% height (p < 0.05). There was also a 
significant difference between the 10 and 30% heights and the 
20 and 30% heights for the TA and MG during the swing phase 
(p < 0.05, Figure 2).
The stroke survivors had significantly smaller global MPF val-
ues of the leading limb during the entire crossing gait cycle (RF: 
130.18 ± 13.33 Hz, BF: 134.67 ± 18.69 Hz, TA: 145.35 ± 12.52 Hz, 
MG: 130.18  ±  13.51  Hz) than the healthy controls (RF: 
139.26 ± 10.21 Hz, BF: 148.40 ± 9.57 Hz, TA: 151.89 ± 6.96 Hz, 
MG: 140.18 ±  17.49 Hz), respectively (p <  0.05). However, no 
significant difference was found in the MPF values of the trail-
ing limb during the entire crossing gait cycle between groups 
(p > 0.05). Figure 3 shows a more detailed comparison of MPF 
FigUre 1 | The rectified and normalized electromyography (eMg) signals of the four muscles of the leading limb of a stroke survivor and a healthy 
control during 10% obstacle height. The solid vertical lines indicate the time of foot contact, the dot vertical lines indicate the time of toe-off, and the dashed 
vertical lines indicate the time of toe-off when crossing the obstacle. Gait cycle 0–1 indicates the cycle before the obstacle, gait cycle 1–2 indicates the crossing 
cycle, and gait cycle 2–3 indicates the cycle after the obstacle. The circle labeled zone is used to demonstrate the phenomenon of cocontraction.
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values in the leading limb at each obstacle height during different 
phases. The MPF of the four muscles of the leading limb was 
significantly smaller in the stroke survivors than the healthy con-
trols (p < 0.05). There was also a decreasing trend (no significant 
difference) for the MPF value of the muscles as the obstacle height 
increased in most conditions. However, the MPF value of the TA 
in the leading limb showed an increasing trend (no significant 
difference) with increasing obstacle height.
We also examined the correlation between the calculated 
variables including activation levels, CI, and MPF values and 
the clinical scales (FMA and BBS). We only found a significant 
positive correlation between the activation of BF and FMA 
(r  =  0.802, p  =  0.017) and a significant negative correlation 
between the activation of TA and FMA (r = −0.817, p = 0.013) 
during the swing phase at the 10% obstacle height (Figure 4). No 
significant difference was found in other situations or between 
other variables and clinical scales.
DiscUssiOn
In this study, we recorded the EMG signals of the four main 
lower limb muscles of stroke survivors and healthy controls 
TaBle 2 | normalized electromyography activation percentages during swing and stance phases for rectus femoris (rF), biceps femoris (BF), tibialis 
anterior (Ta), medial gastrocnemius (Mg) of both leading and trailing limbs: mean (sD).
limb/time Muscle group Obstacle height (% leg length)
10 20 30 effect
Leading limb, swing phase RF Healthy 6.54 (4.06) 6.76 (4.02) 9.49 (8.02) a
Stroke 19.02 (18.44) 17.51 (16.30) 21.71 (19.68)
BF Healthy 11.93 (5.96) 12.70 (4.51) 13.62 (5.48) a
Stroke 16.21 (9.67) 17.74 (7.92) 20.53 (11.25)
TA Healthy 29.14□ (6.23) 30.14d (6.82) 32.66□,d (8.09) a,b,c
Stroke 34.03Δ,□ (10.49) 44.23Δ,○,d (13.89) 56.38□,○,d (16.78)
MG Healthy 19.27 (4.99) 22.91 (7.13) 25.5 (10.47) a
Stroke 34.21 (11.00) 35.98 (17.42) 36.48 (22.5)
Leading limb, stance phase RF Healthy 15.76 (10.52) 18.28 (11.23) 16.63 (12.10) a
Stroke 27.25 (14.68) 31.16 (16.53) 33.20 (14.24)
BF Healthy 21.26 (7.06) 20.33 (5.55) 21.23 (3.89) a
Stroke 23.00 (11.49) 38.55 (12.71) 36.92 (12.47)
TA Healthy 27.13 (12.80) 27.05 (16.72) 27.63d (12.09) c
Stroke 27.24 (7.43) 28.88○ (11.41) 42.08○,d (16.27)
MG Healthy 27.21 (6.66) 29.77 (10.30) 34.05 (11.21) a,b
Stroke 27.75 (11.47) 44.05 (20.79) 42.11 (13.32)
Trailing limb, stance phase RF Healthy 13.61 (8.39) 12.41 (6.91) 12.67 (8.45) a
Stroke 20.03 (12.42) 19.93 (11.8) 31.13 (26.62)
BF Healthy 8.08 (4.49) 8.66 (3.40) 9.42 (4.03) a
Stroke 24.42 (11.26) 28.71 (17.22) 30.38 (14.39)
TA Healthy 21.04 (10.31) 19.34 (7.02) 22.54 (12.12) a
Stroke 36.22 (15.25) 40.38 (11.29) 41.64 (18.34)
MG Healthy 18.05 (5.94) 18.09 (7.58) 21.07 (8.71)
Stroke 28.16 (18.73) 27.94 (17.22) 28.84 (17.82)
Trailing limb, swing phase RF Healthy 8.62 (2.53) 8.39 (2.78) 7.97 (2.77) a
Stroke 14.81 (5.92) 14.04 (4.87) 14.29 (5.44)
BF Healthy 21.97 (8.98) 24.41 (9.57) 29.91 (13.69) b
Stroke 23.18 (11.51) 26.94 (15.68) 29.66 (14.08)
TA Healthy 21.31 (6.74) 29.89 (7.17) 32.04 (5.54) a,b
Stroke 32.46 (12.23) 35.99 (12.05) 44.62 (16.74)
MG Healthy 20.25 (8.44) 22.06 (6.78) 25.32 (9.61) a




dSignificant group effect by post hoc test.
Δ,□,○Significant height effect by post hoc test. “Δ” means significant height effect between 10 and 20% leg length height. “□” means significant height effect between 10 and 30% leg 
length height. “○” means significant height effect between 20 and 30% leg length height.
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during obstacle crossing. Our study demonstrated the activa-
tion levels of the muscles and the coactivation of agonist and 
antagonist muscles were greater, and the MPF values of the 
muscles were lower in the stroke survivors than the healthy 
controls, which indicated abnormal patterns of the gait and 
obstacle crossing following stroke. In addition, the significant 
correlations between the muscle activation of BF, TA, and FMA 
provided a reliable method to analyze the muscles of stroke 
survivors.
Muscle activation level
When crossing the obstacles, the two groups encountered the 
same mechanical challenge (obstacle heights equal to the same 
percentage of leg length), but the stroke survivors showed greater 
overall muscle activation levels than the healthy controls in both 
the leading limb and the trailing limb (Table 2). Postural stability 
and the ability to maintain balance were impaired after stroke. 
Kirker et al. demonstrated that while a normal pattern of hemi-
paretic muscle activation was found in stepping, these muscles 
remained badly impaired in response to a perturbation and com-
pensated by increased activity of the non-paretic muscles (11). 
Obstacle crossing challenges the stroke survivors to the limits of 
their capacity, and they are required to activate a greater level of 
their neuromuscular capacity to walk and safely step across obsta-
cles. This may cause more serious postural instability (6). Similar 
results were also found in children with cerebral palsy. The RF 
and MG activation have been reported to increase in the swing 
phase of gait, which is considered an abnormal activation pat-
tern that results from muscle weakness caused by cerebral palsy 
(26). According to Hahn et  al., the relatively higher activation 
level might lead to muscular fatigue and place stroke survivors at 
higher risk of falls (10).
FigUre 2 | The details of cocontraction index (ci) of each height for both leading and trailing limbs during swing and stance phases. (a) The CI of 
rectus femoris (RF) and biceps femoris (BF) of leading limb during swing phase. (B) The CI of RF and BF of leading limb during stance phase. (c) The CI of tibialis 
anterior (TA) and medial gastrocnemius (MG) of leading limb during swing phase. (D) The CI of TA and MG of leading limb during stance phase. (e) The CI of RF and 
BF of trailing limb during stance phase. (F) The CI of RF and BF of trailing limb during swing phase. (g) The CI of TA and MG of trailing limb during stance phase. 
(h) The CI of TA and MG of trailing limb during swing phase. The asterisk (*) indicates significant effect between groups. The bar (-) indicates significant effect 
between heights.
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We found that the activation level of TA increased with 
increasing obstacle height in the swing phase of both leading and 
trailing limbs in stroke survivors. The TA muscle is the primary 
ankle dorsiflexor and is activated from the initial swing to let the 
ankle joint turn into a neutral position. However, Antonopoulos 
et  al. found no significant height effect of the activation of the 
TA muscle for young adults during obstacle crossing (27). The 
increased activation level of TA in stroke may related to spasticity. 
Because of the excessive coactivation of the antagonist (MG), the 
increased activation level of TA was necessary to ensure a safe 
clearance during obstacle crossing.
Muscle cocontraction
Although cocontraction is inefficient for joint movement, it 
might be important for providing joint stability, especially in 
tasks like obstacle crossing (14). When the leading limb steps 
over an obstacle, the cocontraction of the TA and MG is greater 
in the stroke survivors compared with the healthy controls and 
also increased with increasing obstacle height (Figure  2C). 
The dorsiflexor (TA) strength is weakened after stroke, and 
the cocontraction of the antagonist (MG) might reduce the 
dorsiflexion range but increase the stability during the swing 
phase to ensure safe crossing (28). Also, the cocontraction 
FigUre 3 | The details of mean power frequency (MPF) value of four muscles of the leading limb of each height for both stroke survivors and healthy 
controls during obstacle crossing. (a) The MPF of rectus femoris (RF) during swing phase. (B) The MPF of biceps femoris (BF) during swing phase. (c) The MPF of 
tibialis anterior (TA) during swing phase. (D) The MPF of medial gastrocnemius (MG) during swing phase. (e) The MPF of RF during stance phase. (F) The MPF of BF 
during stance phase. (g) The MPF of TA during stance phase. (h) The MPF of MG during stance phase. The asterisk (*) indicates significant effect between groups.
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of thigh muscles (BF and RF) is greater in the post-obstacle 
stance phase of the leading limb of the stroke survivors com-
pared with the healthy controls, which is helpful to maintain 
balance by controlling the knee position during loading (29) 
(Figure 2B).
The greater cocontraction of the two pairs of lower limb 
muscles with increasing height also indicated muscle weakness 
on the paretic side of stroke survivors, who needed greater cocon-
traction to maintain balance when crossing obstacles of higher 
heights. Muscle cocontraction is also related to postural stability 
FigUre 4 | The correlation between the Fugl-Meyer assessment (FMa) scores and the muscle activation levels when crossing the 10% leg length 
height obstacle. (a) Correlation between FMA scores and muscle activation level of biceps femoris (BF). (B) Correlation between FMA scores and muscle 
activation level of tibialis anterior (TA).
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and dynamic strength in osteoarthritis (30), cerebral palsy (31), 
and Parkinson’s disease (32). The increased muscle cocontraction 
is a metabolically costly process (33), but it may help preserve 
some mobility in those with weakness (34).
When the trailing limb steps over the obstacle, the cocontrac-
tion of the TA and MG also showed a height effect, but there was 
no significant difference between groups during the swing phase 
(Figure 2H). This indicates that the cocontraction might be an 
adaptation strategy for both stroke survivors and healthy controls 
to increase postural stability. Both of the two pairs of lower limb 
muscles showed greater cocontraction in stroke survivors during 
the trailing limb stance phase (Figures  2E,G), which could be 
attributed to the need for greater stability and motor adaptation 
to the weakness of the affected leading limb to support body 
weight (35, 36). With motor recovery, the muscle strength could 
be increased and enable a more efficient strategy with decreased 
muscle cocontraction. Hu et al. investigated the motor function 
recovery process in cases of chronic stroke and found that CI 
values decreased during the recovery process as motor func-
tion improved (24). Assessing muscle cocontraction helps us to 
understand the coordination mechanism in stroke survivors and 
the adaptation strategy they use to ensure safe crossing.
analysis of Power spectrum
The overall power spectrum analysis of all subjects indicated that 
stroke survivors had reduced MPF of the surface EMG in the lead-
ing limb compared with healthy controls (Figure 3). The reduc-
tion in MPF or MF on the paretic side has been report previously 
(16, 17). The decrease in MPF values of the paretic muscles could 
be due to the loss of muscle fibers and impairments in the motor 
unit following stroke. The firing rate has been demonstrated to 
be lower on the paretic side of stroke survivors compared both 
with the non-paretic side of stroke survivors and with the healthy 
controls during contraction (37, 38), which might also cause the 
reduced MPF values.
Alternations in the EMG spectrum have also been reported 
in children with cerebral palsy. Wakeling et al. and Gestel et al. 
found increased MPF value in such children compared with 
asymptomatic controls during gait and related it to the muscle 
dysfunction (26, 39). The assessment of the EMG spectrum could 
be used as an evaluation tool for functional muscle strength. 
No significant difference of MPF was found in the trailing limb 
between stroke survivors and healthy controls. This might be due 
to our instruction to the stroke survivors to use their affected 
side to cross the obstacle first and to use the unaffected limb as 
the trailing limb. This might have taken less effort to cross the 
obstacle and resulted in the lack of a significant between-group 
difference.
Obstacle crossing is a complex task, and the different heights 
place different demands on the subjects. Both groups showed a 
decreasing trend in MPF value with increasing obstacle height in 
the leading limb except for the MPF of the TA (Figure 3). Gabriel 
and Kamen also reported a significant decrease in the spectra 
with the force in the biceps brachii (40). With increased muscle 
activation level, there might be an increased degree of motor 
unit synchronization for the stroke survivors with the increasing 
obstacle height, which was likely to lead to reduction in the MPF 
values and fatigue (41, 42).
correlation
One interesting finding in our study is that there were significant 
correlations between calculated muscle activation levels of BF 
and TA in the leading limb and FMA scores measured by the 
therapists during swing phase at 10% leg length height (Figure 4) 
in stroke survivors. No significant correlation was found between 
muscle activation levels and FMA scores during 20 or 30% leg 
length height obstacle crossing in stroke survivors. Performance 
of stroke survivors was more disturbed during challenging task 
such as for obstacle crossing of higher height (43), and they 
couldn’t take good control of themselves which led to abnormal 
patterns and large variations within group when step across the 
obstacle. The activation level of the BF increased while that of the 
TA decreased with increasing obstacle height. Proximal control 
is more efficient than distal control in the lower limbs for stroke 
survivors to ensure safe obstacle crossing according to kinematic 
analysis (7). Our research showed through EMG analysis that 
stroke survivors with high FMA scores had greater BF activation, 
which controlled the hip joint and knee joint to elevate the toe. 
At the same time, the TA (which is related to ankle dorsiflexion) 
was abnormally activated to a larger degree in the face of fall 
risk among stroke survivors with lower FMA scores. Similar to 
Li et al., we found no significant correlation between the MPF 
values and clinical scales or between CI and clinical scales (16). 
Nevertheless, the significant correlation between the muscle 
activation levels and FMA scores means that it is reliable to use 
EMG signals to analyze the muscles of stroke survivors.
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limitations
This study has several limitations. The recruited stroke survivors 
in this study had good function, so the results might not be useful 
for moderate or severe stroke survivors. We instructed the stroke 
survivors to use their hemiparetic side to take the first step over 
the obstacle and to use the unaffected side as the supporting limb, 
which is safer for them. We neglected situations using the other 
limb as the leading limb, which might lead to a minor difference 
in the results. Moreover, significant differences between stroke 
survivors and healthy controls should also be interpreted with 
caution considering the relatively small sample size. We plan to 
recruit more stroke survivors of different functional levels and 
to instruct them to use both limbs as the leading limb in future 
work to obtain a more comprehensive understanding of the 
neuromuscular changes.
conclusion
In this study, stroke survivors were recruited to step across 
obstacles of three different heights and compared with healthy 
controls to investigate motor control mechanisms that could 
not be reflected during level walking. Although the stroke sur-
vivors could safely step across the obstacles, they demonstrated 
abnormal motor control patterns, such as greater overall muscle 
activation level and larger cocontraction of the agonist and 
antagonist muscles. These might result in muscle fatigue, which 
would lead to a high risk of tripping and higher energy cost. 
The reduction in the MPF values of the paretic side of stroke 
survivors could be related to impairments of the motor unit or 
other complex neuromuscular alterations. The decreasing trend 
of the MPF values when crossing higher heights might due to 
greater motor unit synchronization, which could also lead to 
fatigue. The significant correlations between muscle activation 
levels and clinical scales provided a reliable method of analyzing 
the muscle functions of stroke survivors. These findings could 
help therapists to understand the neuromuscular changes fol-
lowing stroke and work out specific methods for rehabilitation 
of the lower limb muscles.
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